Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options

Basit Öğe Kaydı
dc.authoridVamvakidis, Kyriakos/0000-0002-1663-4839
dc.authoridEmre, Ali Ugur/0000-0002-1136-0517
dc.authoridAkinci, Baris/0000-0002-8634-4845
dc.authoridMIHAI, Radu/0000-0001-6153-1970
dc.authoridAGCAOGLU, Orhan/0000-0003-1617-3953
dc.authoridşenyürek, yasemin/0000-0001-5339-1840
dc.authoridSonmez, Alper/0000-0002-9309-7715
dc.authorwosidVamvakidis, Kyriakos/AAE-4680-2021
dc.authorwosidŞahin, İbrahim/HHY-8303-2022
dc.authorwosidEmre, Ali Ugur/JWA-0250-2024
dc.authorwosidCanturk, Zeynep/JWP-3262-2024
dc.authorwosidAkinci, Baris/AAS-4773-2020
dc.authorwosidMIHAI, Radu/S-7992-2019
dc.authorwosidCELIK, OZLEM/A-5240-2018
dc.contributor.authorAgcaoglu, Orhan
dc.contributor.authorSezer, Atakan
dc.contributor.authorMakay, Ozer
dc.contributor.authorErdogan, Murat Faik
dc.contributor.authorBayram, Fahri
dc.contributor.authorGuldiken, Sibel
dc.contributor.authorRaffaelli, Marco
dc.date.accessioned2024-06-12T10:58:22Z
dc.date.available2024-06-12T10:58:22Z
dc.date.issued2022
dc.departmentTrakya Üniversitesien_US
dc.description.abstractPurpose The COVID-19 pandemic brought unprecedented conditions for overall health care systems by restricting resources for non-COVID-19 patients. As the burden of the disease escalates, routine elective surgeries are being cancelled. The aim of this paper was to provide a guideline for management of endocrine surgical disorders during a pandemic. Methods We used Delphi method with a nine-scale Likert scale on two rounds of voting involving 64 experienced eminent surgeons and endocrinologists who had the necessary experience to provide insight on endocrine disorder management. All voting was done by email using a standard questionnaire. Results Overall, 37 recommendations were voted on. In two rounds, all recommendations reached an agreement and were either endorsed or rejected. Endorsed statements include dietary change in primary hyperparathyroidism, Cinacalcet treatment in secondary hyperparathyroidism, alpha-blocker administration for pheochromocytoma, methimazole +/- beta-blocker combination for Graves' disease, and follow-up for fine-needle aspiration results of thyroid nodules indicated as Bethesda 3-4 cytological results and papillary microcarcinoma. Conclusion This survey summarizes expert opinion for the management of endocrine surgical conditions during unprecedented times when access to surgical treatment is severely disrupted. The statements are not applicable in circumstances in which surgical treatment is possible.en_US
dc.identifier.doi10.1007/s13304-021-00979-8
dc.identifier.endpage335en_US
dc.identifier.issn2038-131X
dc.identifier.issn2038-3312
dc.identifier.issue1en_US
dc.identifier.pmid33840069en_US
dc.identifier.scopus2-s2.0-85104137941en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage325en_US
dc.identifier.urihttps://doi.org/10.1007/s13304-021-00979-8
dc.identifier.urihttps://hdl.handle.net/20.500.14551/20041
dc.identifier.volume74en_US
dc.identifier.wosWOS:000639062800001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringer-Verlag Italia Srlen_US
dc.relation.ispartofUpdates In Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectConsensusen_US
dc.subjectEndocrine Diseaseen_US
dc.subjectExpert Opinionen_US
dc.subjectPandemicen_US
dc.subjectQualtricsen_US
dc.subjectSurveyen_US
dc.titleManagement of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical optionsen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu